baber/WOPTO huggingface dataset:
Patent JP-3487852-B2 (JP)
IPC: C07K14/54
Filed: 1993-09-10
Granted: 2004-01-19
Abstract: The present invention features isolated DNA encoding allergens of Dermatophagoides (house dust mites) particularly of the species Dermatophagoides farinae and Dermatophagoides pteronyssinus, which are protein allergens or peptides which include at least one epitope of the protein allergen. In particular, the invention provides DNA encoding the major D. farinae allergens, Der f I and Der f II and DNA encoding the major D. pteronvssinus allergens, Der p I and Der p II. The present invention further relates to proteins and peptides encoded by the isolated D. farinae and D. pteronvssinus DNA, including proteins containing sequence polymorphisms. In addition, the proteins or peptides encoded by the isolated DNA, their use a diagnostic and therapeutic reagents and methods of diagnosing and treating sensitivity to house dust mite allergens, are disclosed.
Patent JP-3530528-B2 (JP)
IPC: A61B18/04
Filed: 1992-11-05
Granted: 2004-05-24
Abstract: An ablation electrode carries a temperature sensing element for measuring the temperature of the tissue being ablated. A thermal insulating element associated with the sensing element blocks the transfer of heat energy from between the temperature sensing element and the body. The temperature sensing element therefore measures temperature without being affected by the surrounding thermal mass of the electrode.
Patent JP-3604702-B2 (JP)
IPC: C07B61/00
Filed: 1997-09-17
Granted: 2004-12-22
Abstract: The subject-matter of the invention is a process for the preparation of substituted 4-methylbiphenyls of general formula:in which R is a cyano group or a protected tetrazolyl group of formula:in which R1, situated at the 1 or 2 position of the tetrazolyl group, is a protective group, characterized in that a halobenzene of formula:in which Hal is a halogen atom and R has the same meaning as above, is reacted with a p-tolylmagnesium halide in the presence of a linear or branched polyether and of a catalyst comprising a transition metal.
Patent JP-3231783-B2 (JP)
IPC: A61F13/15
Filed: 1996-10-16
Granted: 2001-11-26
Abstract: The present invention provides an absorbent article which includes a first absorbent article and a second absorbent article releasably secured to one another. The first and second absorbent articles are releasably secured to one another by at least one periphery securement member that is positioned along and extends outwardly from a portion of the periphery of the second absorbent article.
Patent JP-3194047-B2 (JP)
IPC: F15B1/02
Filed: 1996-11-01
Granted: 2001-07-30
Abstract: PCT No. PCT/CH96/00386 Sec. 371 Date May 1, 1998 Sec. 102(e) Date May 1, 1998 PCT Filed Nov. 1, 1996 PCT Pub. No. WO97/17546 PCT Pub. Date May 15, 1997In order to maintain high efficiency close, to isothermy despite high frequencies in a pneumo-hydraulic converter with reciprocating pistons, pipe cluster-heat exchange pipes (38) are provided in the gas working chambers of the converter and the exchange fluid in the pipes is kept at approximately ambient temperature. For this the gas working chambers must be arranged axially next to one another and, in order to eliminate dead space, connected in pairs by conical exchange valves (12a/12b) which take in the entire wall thickness of the valve flange (5a/5b) dividing the air chambers.
Patent JP-3579737-B2 (JP)
IPC: C08F299/08
Filed: 1992-08-06
Granted: 2004-10-20
Abstract: Organosiloxane compositions curable to optically clear, high refractive index elastomers are disclosed. The cured compositions have superior post-folding high resolution recovery making them suitable for fabricating foldable intraocular lenses used in small-incision ophthalmic surgeries. The organosiloxane compositions include first and second vinyl terminated organosiloxanes of about 18 mole % diphenylsiloxane and about 82 mole % dimethylsiloxane, fumed silica, crosslinking reagent, platinum containing catalyst, and optional ultraviolet absorbing compounds. The first and second vinyl terminated organosiloxanes differ in molecular weight resulting in a bimodal molecular weight distribution in the compositions.
Patent JP-3643842-B2 (JP)
IPC: G01N21/76
Filed: 1994-04-01
Granted: 2005-04-27
Abstract: A glucose monitor, and related method, determines the concentration of glucose in a sample by monitoring fluorescent light produced directly by any glucose present in the sample. The glucose monitor illuminates the sample with ultraviolet excitation light that induces any glucose present in the sample to fluoresce, with the fluorescent light being monitored and processed to determine the concentration of glucose in the sample. A sensor monitors the return light, which includes fluorescent light produced by any glucose in the sample, and generates first and second electrical signals indicative of the intensity of light in two wavelength bands. One wavelength band includes a characteristic spectral peak of glucose fluorescence, and the other wavelength band is a reference band having known spectral characteristics. A processor then processes the first and second electrical signals to determine the concentration of glucose in the sample. A fiber-optic waveguide is used to guide the excitation light from the laser light source to the sample and the return light from the sample to the sensor. The fiber-optic waveguide is housed in a catheter or probe that is adapted to monitor the concentration of glucose percutaneously in the oral cavity tissues of a person's mouth such as the gums. <IMAGE>
Patent JP-3217067-B2 (JP)
IPC: A61B3/12
Filed: 1993-04-21
Granted: 2001-10-09
Abstract: Apparatus is provided for determining the topography, thickness, and fiber orientation of the nerve fiber layer at the fundus of the eye by measuring the polarization shift induced in a return beam of polarized light which is reflected at the ocular fundus from an incident beam of a known polarization state. A corneal polarization compensator effectively cancels the birefringent effects of the cornea and other portions of the eye anterior to the fundus, so that clinically meaningful results are produced.
Patent JP-3233645-B2 (JP)
IPC: G01L7/00
Filed: 1998-11-13
Granted: 2001-11-26
Abstract: A gage mechanism for a blood pressure measuring device or other similar apparatus includes a supported shaft member having one end in contact with an inflatable bellows. A pointer is attached at an opposite end of the shaft and a helically wound spring is attached to the shaft and a supporting structure. As the bellows inflates, the shaft is axially displaced and causes rotation due to the constraint of the helical ribbon spring, causing a corresponding angular deflection of the attached pointer relative to an indicating scale. The mechanism includes a first adjustment member for allowing the pointer to be preset to a zero or calibrated position, and a second adjustment mechanism that controls the amount of angular rotation of the shaft and pointer for a displacement of the bellows.
Patent JP-4060373-B2 (JP)
IPC: H04N5/44
Filed: 1998-03-23
Granted: 2008-03-12
Abstract: A device for recording an information signal in a record carrier without loss of part of an information signal at the beginning of a recording, includes a processing circuit for processing an information signal and for supplying a recording information signal, an input device for supplying activation information and wait information, and an operating device for recording, after the activation information, a recording information signal in the record carrier and, after the wait information, for consecutively overwriting storage in a temporary store. An area of the record carrier is selected as the temporary store, and the operating device starts consecutively overwriting storage of a recording information signal in the selected temporary store after the wait information, and stops a consecutively overwriting storage after the activation information.
Patent JP-3899128-B2 (JP)
IPC: A61M1/36
Filed: 1996-05-08
Granted: 2007-03-28
Abstract: A method and device is described for direct removal of heparin from whole blood during extracorporeal therapy. In clinical situations where the blood is heparinized to prevent clotting in the extracorporeal circuit containing e.g., a hemodialysis cartridge or a heart-lung machine, it would be desirable to eliminate the systemic heparinization of the patients. The extracorporeal circuit contains a device having antithrombin III immobilized and inserted between the outlet port of the primary extracorporeal device, such as the hemodialysis cartridge or heart-lung machine and the patient. When the heparinized blood comes in contact with the immobilized antithrombin III, heparin is removed and the reperfused blood is substantially free of heparin. The advantage of the system lies in the fact that heparin is removed from the blood rather than neutralized. This helps overcome the adverse reactions and side effects associated with the use of heparin anticoagulation.
Patent JP-4394164-B2 (JP)
IPC: A61F13/02
Filed: 1997-05-23
Granted: 2010-01-06
Abstract: A dressing for covering a portion of the anatomical surface of a living being, said dressing being able to adhere to the skin, the mucosa and/or a wound on any portion of a living being without exposing the skin to a significant stress after application and said dressing showing a permanent deformation created before, during or after application of the dressing and wherein the dressing is optionally covered in part or fully by one or more release liners or cover films to be removed before or during application.
Patent JP-3467043-B2 (JP)
IPC: C07C321/28
Filed: 1998-04-03
Granted: 2003-11-17
Abstract: A process for the manufacture of a phenylthiobutyl-isoquinoline of formula (II) and novel intermediates therefor.
Patent ES-2285887-B2 (ES)
Title: Caja autoportante de madera adecuada para el soporte y el aislamiento termico de una membrana de tanque estanco.
Inventor: DHELLEMMES JACQUES
IPC: B65D90/02
Filed: 2005-02-21
Granted: 2009-06-30
Abstract: Caja autoportante de madera adecuada para el
soporte y el aislamiento térmico de una  membrana de tanque estanco
que comprende un panel de fondo, pantallas laterales que  sobresalen
perpendicularmente en un lado del citado panel de fondo para
delimitar el  contorno de un espacio interior de la citada caja, una
pluralidad de tabiques internos (14)  mutuamente paralelos y
perpendiculares al citado panel de fondo que se extienden entre  las
citadas pantallas laterales de manera que dividen el citado espacio
interior en una  pluralidad de compartimientos destinados a recibir
una guarnición calorífuga, y un panel  de tapa, caracterizada por el
hecho de que comprende, al menos, un elemento rigidizador  (16) que
está dispuesto en el citado espacio interior transversalmente a los
citados  tabiques internos y que presenta una zona de acoplamiento
(17, 18) con cada uno de los  citados tabiques internos para
aumentar la resistencia al pandeo de los citados tabiques  internos,
extendiéndose la citada zona de acoplamiento en una altura superior
o igual a la  mitad de la distancia entre los citados paneles de
fondo y de tapa.
Patent AU-2001228675-B2 (AU)
Title: Apparatus for securing a closure in an aperture of a container
Inventor: PIEPEREIT EDWARD JOHN
IPC: B65G69/18
Filed: 2001-01-26
Granted: 2006-05-18
Abstract: An apparatus 1 for securing a closure 2 in an aperture 3 of a container 4 comprises a securing cap 5 adapted to engage the closure 2 and the container 4 to secure the closure 2 , and fittings to provide for generation and release of a vacuum or partial vacuum between the securing cap 5 and the closure 2 to move the securing cap 5 into a securing position.
Patent AU-2001230956-B2 (AU)
Title: O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
Inventor: SHAW LESLIE M
IPC: G01N33/50
Filed: 2001-01-12
Granted: 2005-08-18
Abstract: The present invention relates to methods of alleviating and inhibiting a Iymphoproliferative disorder in a mammal, the method comprising administering one or more rapamycin derivatives (including rapamycin) to the mammal (see figure 8). Further, the invention provides a method for identifying agents which are useful for alleviating and inhibibing Iymphoproliferative disorders, as well as a method for identifying agents which are capable of inhibiting metastasis of lymphatic tumors in a mammal.
Patent AU-2001279639-B2 (AU)
Title: Method for electrophoretically separating membrane proteins
Inventor: BAYERL THOMAS
IPC: C07K1/26
Filed: 2001-06-01
Granted: 2006-09-21
Abstract: The one and two-dimensional separation of proteins extending through the membrane (membrane proteins) is a prerequisite for a complete analysis of the proteome of a functionally intact cell organelle. A substantial drawback of prior art methods for separating is that their applicability is limited to peripheral water-soluble proteins. The aim of the novel method is to electrophoretically separate membrane proteins in one or two dimensions. To this end, membranes from cell organelles, whose membrane protein stock should be separated, are placed on planar supports whose surface was modified using suitable methods in such a manner that the membrane proteins maintain their ability to laterally diffuse in the membrane plane after being placed on the support. By subsequently applying electrical fields, the proteins can be electrophoretically displaced in the membrane plane and, as a result, can be separated in one or two dimensions according to their different charge characteristics.
Patent AU-2002241588-B2 (AU)
Title: Control of solution catalyst droplets
Inventor: GOODE MARK GREGORY
IPC: C08F2/00
Filed: 2001-12-05
Granted: 2005-11-10
Abstract: A process, carried out in the gas phase, comprising contacting one or more olefins with a catalyst system containing a carrier gas and a mixture of solids comprising a transition metal compound or complex and a liquid organic solvent, under polymerization conditions, in a fluidized bed reactor containing resin particles in a fluidized state with the provisos that (a) the mixture of solids and solvent contains at least about 95 percent by weight solids and (b) the mixture is sprayed with the carrier gas into a particle-lean zone, or the fluidized bed, of the reactor.
Patent AU-2002300838-B2 (AU)
Title: Hybrid Compressor
Inventor: TERAUCHI KIYOSHI
IPC: F04B35/04
Filed: 2002-09-02
Granted: 2005-06-02
Abstract: A hybrid compressor includes a first compression mechanism, which is driven by a first drive source, and a second compression mechanism, which is driven by a second drive source. A first discharge port of the first compression mechanism and a second discharge port of the second compression mechanism are connected to a single discharge path. <IMAGE>
Patent AU-2002301663-B2 (AU)
Title: A method of constructing a rail track on a concrete slab and a temporary tie plate for use in the method
Inventor: RADA NICOLAS
IPC: E01B29/06
Filed: 2002-10-28
Granted: 2007-10-18
Abstract: Rails (2) pre-mounted on their tie plates (11) are suspended above the location at which a concrete slab is to be poured. The position of the rails is then adjusted to move the bottom plate of temporary tie plates, disposed under the base of each tie plate, accurately to the location at which the tie plates must rest. Concrete slab is then poured up to the height of the temporary tie plates. <??>The rails are raised, after which the temporary tie plates are removed. The rails are then positioned on the slab, with the tie plates fixed to the corresponding anchor members. An Independent claim is also included for a temporary tie plate.
Patent AU-2002359875-B2 (AU)
Title: Tetrahydroquinoline analogues as muscarinic agonists
Inventor: FRIBERG BO LENNART MIKAEL
IPC: A61K31/55
Filed: 2002-12-23
Granted: 2009-01-08
Abstract: The present invention relates to tetrahydroquinoline compounds as muscarinic receptor agonists; compositions comprising the same; methods of inhibiting an activity of a muscarinic receptor with said compounds; methods of treating a disease condition associated with a muscarinic receptor using said compounds; and methods for identifying a subject suitable for treatment using said compounds.
Patent AU-2003206321-B2 (AU)
Title: Method and device related to a container
Inventor: LINDSKOG KJELL
IPC: G08B15/00
Filed: 2003-02-05
Granted: 2008-05-29
Abstract: The invention pertains to a method and to an arrangement applicable to a container or to a chamber, for instance to a security chamber for valuable articles. The container/chamber(20) has a casing or shell (10) in which an explosive substance or a burstable item is housed. The arrangement has a detector (50, 50') at the shell (10) for detecting ambient temperature or shell temperature. The explosive substance is detonated or the burstable item is depressurised to prevent bursting of the outer casing/shell (10)of the container or the chamber at a predetermined temperature limit value. The detector (50, 50') for detecting the ambient temperature or the shell temperature is disposed essentially across the whole surface of the shell/casing (10).
Patent AU-2003227529-B2 (AU)
Title: System for loading and unloading unit loads into a cargo hold, in particular of an aircraft, and intermediate transport device or corresponding transport unit
Inventor: HELMNER ANDERS
IPC: B64D9/00
Filed: 2003-03-11
Granted: 2009-06-11
Abstract: At least one intermediate conveyor device (2) is located between the aircraft end of the runway conveyor (4) and the front end of the transport device (14) inside the cargo hold (1). During loading, the load (6) is initially transported in the width direction of the aircraft towards a deeper position inside the aircraft fuselage and then transported in the aircraft length direction to the front end of the transport device. During unloading, the load is transported in the width direction of the aircraft from the front end of the transport device and out through the open cargo hold door. Independent claims are also included for (a) the intermediate conveyor device and (b) a conveyor unit comprising the intermediate conveyor device and runway conveyor.
Patent AU-2003255695-B2 (AU)
Title: Use of hesperidin or one of its derivatives for making a medicine for bone formation stimulation
Inventor: HORCAJADA MARIE-NOELLE
IPC: A23L33/00
Filed: 2003-06-27
Granted: 2008-04-03
Abstract: The invention relates to the use of the compound hesperidin or of one of its derivatives for the manufacture of a composition designed to stimulate bone formation and/or inhibit bone resorption in man or animals.
Patent AU-2003296731-B2 (AU)
Title: Methods for preserving and/or storing cells having a nitrilase or nitrile hydratase activity
Inventor: HAUER BERNHARD
IPC: A01N1/02
Filed: 2003-12-24
Granted: 2009-07-09
Abstract: The invention relates to a method for preserving and/or storing microorganisms which exhibit at least one nitrile hydratase or nitrilase enzyme activity, with the preservation and/or storage being effected in an aqueous medium which comprises at least one aldehyde, with the total aldehyde concentration being in a range from 0.1 to 100 mM/l.
Patent AU-2004276723-B2 (AU)
Title: Real-time multistage infrared image-based tracking system
Inventor: CONTINI CASEY LEONARD
IPC: G01S/
Filed: 2004-05-21
Granted: 2010-05-20
Abstract: A multi-stage infrared (IR) image-based tracking system is provided that accurately identifies and tracks targets across a variety of different situations and environmental conditions. The system includes primary and secondary trackers. The secondary tracker supports the primary tracker by identifying and tracking targets when the primary tracker loses or fails to identify one or more targets, and helps the primary tracker reacquire valid targets. In an exemplary embodiment of the invention, the primary tracker is a correlation-based tracker, and the secondary tracker is a feature-based tracker. A prescreener is also included, which operates concurrently with the correlation-based and feature-based trackers to generate a list of possible targets. The list can be used to provide a confidence level for the probable targets identified by each of the primary and secondary trackers.
Patent AU-2004303600-B2 (AU)
Title: Tunable segmented polyacetal
Inventor: BROWN MALCOLM
IPC: A61L27/58
Filed: 2004-12-22
Granted: 2010-10-14
Abstract: The present invention relates to polymer compositions namely biodegradable segmented block copolymers comprising polyol residues having a number average molecular weight of at least 4000 Daltons and in that the polyols are connected by actual linkages.
Patent AU-2005209434-B2 (AU)
Title: Elevator door monitoring arrangement
Inventor: PERALA PEKKA
IPC: B66B5/00
Filed: 2005-01-17
Granted: 2009-08-20
Abstract: The method of the present invention can be used to monitor and predict the condition of an automatic door of an elevator or more generally an automatic door in a building. In the method, the acceleration or velocity of the door is measured and a dynamic model of the door is created. Using the model, estimated values of acceleration or velocity of the door can be calculated as a function of unknown parameters. One of the unknown parameters is the frictional force acting on the door during movement. By utilizing the estimated acceleration or velocity as well as measured acceleration or velocity values, an error function is obtained, whose minimum value is found using an optimizer. The unknown parameters corresponding to the minimum value indicate the current condition of the door. On the basis of earlier measurement results, it is additionally possible to predict a point of time when a failure is likely to occur in the operation of the door. In addition to unknown force parameters, it is possible, using a genetic algorithm, to determine the operational condition of a door closing device as well.
Patent AU-2005235309-B2 (AU)
Title: Beneficial effects of increasing local blood flow
Inventor: FOSSEL ERIC THOR
IPC: A61K47/18
Filed: 2005-04-19
Granted: 2012-07-26
Abstract: The present invention generally relates to the improvement of tissue health by increasing local blood flow. In some aspects of the invention, increased local blood flow is effected by the transdermal delivery of the nitric oxide precursor L-arginine and/or its derivatives alone, or optionally in conjunction with an adjunct such as theophylline. The transdermal delivery is effected, in certain embodiments through the means of a hostile biophysical environment, such as that created by a high ionic strength environment. Various pathological states caused by, or occurring in conjunction with, insufficient blood flow, can be treated using the systems and methods of the invention as described herein. In other embodiments, increased blood flow using the systems and methods of the invention may result in enhanced healing, for example, through greater availability of the constituents of the blood. Examples of conditions which may benefit from increased blood flow include, but are not limited to, erectile dysfunction, hair loss, female sexual dissatisfaction, sagging facial or other body tissue, peripheral vascular disease including claudication, neuropathy, skin ulcers, bone healing, wound healing, viral and bacterial infection, and skin grafting.
Patent AU-2005284445-B2 (AU)
Title: Information point
Inventor: KORTE OLAF
IPC: G01C21/20
Filed: 2005-09-07
Granted: 2010-02-11
Abstract: Information point having a provider for providing a data structure having entries about different objects, wherein a limited geographical area is associated to every object, and wherein object information is associated to every object, a determiner for determining a geographical position of the information point, an examiner for examining whether the geographical position of the information point lies in the geographical area associated to an object, and a provider for providing object information associated to an object, if the examiner has determined that the information point lies in the geographical area of the object.